Maia Biotechnology, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

AMEX
MAIA Biotechnology announces its 2026 Annual Meeting of Stockholders to be held virtually on May 21, 2026, with key proposals including director elections and auditor ratification.
AMEX
MAIA Biotechnology, Inc. has filed a definitive proxy statement with the SEC.
AMEX
MAIA Biotechnology is holding its annual shareholder meeting virtually on May 22, 2025, to vote on director elections, auditor ratification, and an increase in authorized common stock.
AMEX
MAIA Biotechnology announces its 2024 Annual Meeting of Shareholders to be held virtually on May 24, 2024, to vote on director elections and the ratification of the company's independent auditor.